FDA & Prescription Drugs

• Novartis' Diabetes Drug Galvus

  Joe Saunders | November 07, 2007 10:42 AM | 0 CommentsPinellas, FL

  Novartis AG has decided to delay it diabetes drug Galvus because of concerns with liver toxicity problems. The drug is supposed to compete favorably with Merck's diabetes drug Januvia but problems with high dosage of Galvus has forced its delay to the market. Januvia is a once daily diabetes drug that works in a similar fashion to Galvus but doesn't have the same liver toxicity concerns as...

• Bayer Pulls Heart Surgery Medication

  Amy Schauers | November 06, 2007 5:25 PM | 0 CommentsSalt Lake City, UT

  After a study showed that the heart surgery drug Trasylol increases death rates, the pharmaceutical company Bayer pulled the drug. The study was the latest in a series of worrisome signs that Trasylol could be dangerous. Last year, a study published in The New England Journal of Medicine found that the drug increased the risks of kidney failure, heart attack and stroke. That research concluded...

• Heart Surgery Drug Suspended From Market

  Scott Kappes | November 06, 2007 4:36 PM | 0 CommentsHouston, TX

  Yesterday the FDA and Bayer Pharmaceutical Corp. announced that Trasylol is being pulled from the U.S. market. This news comes after a Canadian study suggested that it might cause an increased risk of death. The controversial drug is used to treat patients who have an elevated risk of excessive bleeding during heart surgery. The study was discontinued when preliminary results suggested this...

• Bayer Halts Sales of Trasylol Globally

  Gerry McGill | November 06, 2007 3:27 PM | 0 CommentsBiloxi & Gulfport, MS

  Bayer AG halted worldwide sales Monday of its anti-bleeding drug Trasylol at the request of U. S. and foreign health officials pending further analysis of a Canadian study that suggests it's linked to a 50 percent higher risk of death than the other drugs in the clinical trial. The Food and Drug Administration asked the company to stop selling the drug, used to prevent excessive bleeding during...

• Bayer Stops Selling Trasylol

  Shannon Weidemann | November 05, 2007 8:51 PM | 0 CommentsNew York City, NY

  The blood clotting drug Trasylol will no longer be sold by Bayer AG after studies have shown there is an increased risk of death from using the drug. The recalled drug increases the risk of kidney damage when used during heart bypass surgery. The FDA cannot identify a patient population in which the use of Trasylol (aprotinin) outweighs the risk, Dr. John K. Jenkins, director of the FDA's...

• Marketing Suspended for Bayer's Trasylol

  Scott Kappes | November 05, 2007 2:23 PM | 0 CommentsHouston, TX

  Today the FDA announced that at their request Bayer Pharmaceuticals Corp. has agreed to immediately cease all marketing associated with Trasylol. This comes as a follow up to a report from October 26 that suggested that their may be an increased risk of death connected to the drug used to control bleeding during heart surgery. The preliminary results of a Canadians study on Trasylol suggest this...

• Trasylol Pulled From Market

  Shannon Weidemann | November 05, 2007 1:17 PM | 0 CommentsColorado Springs, CO

  The antibleeding drug Trasylol has been pulled from the market around the world after a study has shown there may be an increased risk of death from use. The drug is used during heart bypass surgery. The announcement came as a Canadian study comparing the safety and efficacy of Trasylol with two others was halted. Preliminary results from that trial also suggested Trasylol increased the risk...

• Trasylol Sales Stopped by Manufacturer

  Ed Normand | November 05, 2007 1:01 PM | 0 CommentsOrlando, FL

  Bayer has stopped sales of the anti-bleeding drug Trasylol. The sales ban is in response to a recent Canadian study documenting the risks of death in using Trasylol. The FDA could not advocate continued use of the product where the use of it is not outweighed by the risks. Product liability actions can be considered against drug manufacturers that sell a defective or dangerous drug. If you...

• Heart ByPass Drug Recalled

  Robert Blanchard | November 05, 2007 12:06 PM | 0 CommentsPensacola, FL

  If you are soon to receive a heart bypass, at least you won't face the propsect ohf being given the medication known as Trasylol. After consultation with agencies in the U.S., Canada, and Germany, the drug manufacturer has announced that it is wiithdrawing the drug worldwide. See Article. The FDA approved the drug in 1993 and started re-evaluating the drug's side effects after the publication ...

• Bayer Withdraws Trasylol

  Brooks Schuelke | November 05, 2007 11:39 AM | 0 CommentsAustin, TX

  Under pressure from the Food and Drug Administration, Bayer announced today that it is suspending its global sales of Trasylol. The drug, primarily used to help with bleeding during heart surgeries, has been linked to higher instances of death, serious kidney damage, and stroke. Bayer has been under attack for problems relating to Trasylol for more than a year after Bayer failed to provide the...